Google DeepMind dismantles Nobel-winning AlphaFold team in strategy shift - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
商业快报

Google DeepMind dismantles Nobel-winning AlphaFold team in strategy shift

Landmark project that solved protein folding gives way to a wider race to build AI systems for scientific discovery
00:00

{"text":[[{"start":8.78,"text":"Google DeepMind has dismantled the team behind AlphaFold, its Nobel Prize-winning AI system for predicting protein structures, as the company overhauls the research strategy that made it one of the world’s leading AI laboratories."}],[{"start":22.28,"text":"The majority of the original authors of the AlphaFold papers have been reassigned over the past year, according to an FT analysis of recent job moves and people familiar with the matter."}],[{"start":33.02,"text":"DeepMind confirmed the staffers have moved internally to projects built around Google’s Gemini large language model, as well as areas including enzyme design, nuclear fusion and genomics."}],[{"start":44.6,"text":"Others have relocated to Alphabet’s drug-discovery company Isomorphic Labs. Nearly a quarter of the full-time Google DeepMind authors of the original AlphaFold papers have left the company altogether."}],[{"start":55.92,"text":"The reshuffle reflects a significant change in DeepMind’s scientific strategy since the rise of large language models."}],[{"start":61.76,"text":"“Our strategy over the last nine years has been to focus on grand challenges . . . a concrete goal every project is focused on,” said Pushmeet Kohli, vice-president of research at Google DeepMind, where he founded and leads the AI for Science team. “The strategy has evolved.”"}],[{"start":78.56,"text":"He said rather than simply organising researchers around single scientific problems such as protein folding, the AI lab is now also focused on building Gemini-powered systems that can assist scientists — and eventually automate parts of the scientific process — while competing with OpenAI and Anthropic to develop frontier AI agents."}],[{"start":97.6,"text":"AlphaFold, which DeepMind began developing in 2018, transformed biological research by using AI to predict the three-dimensional structure of proteins, a breakthrough that earned John Jumper, vice-president, engineering fellow, and DeepMind chief executive Demis Hassabis, a Nobel Prize in Chemistry in 2024."}],[{"start":116.76,"text":"The project became the defining example of DeepMind’s strategy of pursuing long-term scientific breakthroughs through dedicated research teams."}],[{"start":125.12,"text":"Earlier this year, Jumper and fellow AlphaFold researcher Jonas Adler moved to Google’s internal “Code Strike” team, a group assembled to improve the company’s AI coding capabilities as it seeks to catch Anthropic and OpenAI."}],[{"start":137.76,"text":"Last month, Jumper announced he was leaving for Anthropic, where he will be joined by Adler and AlphaFold colleague Alexander Pritzel."}],[{"start":145.28,"text":"A DeepMind employee, who asked not to be named, said all three had been “instrumental, important, core members” of the company and that their departures had sparked surprise internally."}],[{"start":156.32,"text":"DeepMind said the movement of researchers reflected its evolving scientific priorities."}],[{"start":161.8,"text":"“We are incredibly proud of our scientific heritage and the global impact of AlphaFold, which inspired the launch of Isomorphic Labs with the mission to reimagine drug discovery,” the company said."}],[{"start":173.2,"text":"Isomorphic Labs was spun out of DeepMind in 2021 to commercialise AlphaFold’s scientific breakthroughs. It has since struck partnerships with pharmaceutical companies including Novartis and Eli Lilly as it seeks to use AI to speed drug discovery."}],[{"start":188.08,"text":"The reorganisation also reflects a broader shift across the AI industry, as frontier labs increasingly view large language models not simply as chatbots but as tools capable of accelerating scientific research. Anthropic this year launched Claude Science, a version of its AI assistant designed to support research in biology and drug discovery."}],[{"start":208.56,"text":"Competition for the small pool of researchers capable of building frontier AI systems has intensified alongside that strategic shift, with companies aggressively recruiting top scientists and engineers."}],[{"start":219.8,"text":"“[AI researchers] want to work for a lab that is at the frontier and [not] have to play a catch-up game,” Mark Chen, OpenAI’s head of research, told the FT earlier this year."}],[{"start":229.56,"text":"“It’s much more exciting for a researcher to just be at the frontier, trying to push the next paradigm, rather than all this pressure to replicate some model that is close to the frontier,” he added."}],[{"start":244.36,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1785308730_7033.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

美债收益率冲击下,欧洲必须自寻出路

埃里安:欧洲不能只盼着大西洋彼岸的借贷成本回落,它必须着手解决自身问题。

AI与通胀:央行行长该担忧到什么程度?

凯恩斯:这取决于一个价值万亿美元问题的答案:AI是否真能带来预期的生产力提升?

印度企业界的乐观情绪站得住脚吗?

印度企业界公开表达的乐观情绪,与家庭和投资者的焦虑情绪之间的落差日益明显。

Lex专栏:中国药企在药品开发领域获得一席之地

外国制药集团如今开始购买中国本土开发创新药物的授权。

特斯拉与太空探索技术公司:以马斯克为中心的庞大企业星系

埃隆•马斯克旗下上市公司的合并有一定道理,但其他股东最终可能不如现在有影响力。

火箭、机器人和风险:马斯克的3.6万亿美元豪赌

全球首富试图促成迄今最大胆的一笔合并交易,但他还需要说服股东和全球监管机构。
设置字号×
最小
较小
默认
较大
最大
分享×